India is the hub of our R&D strength, process innovation and regulatory excellence
Jeevan Kasara, Chairman of the Board, STERIS Healthcare, believes India’s next pharma growth story will be built on trust,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
R&D
AI: Revolutionising Pharma R&D
From one-size-fits-all to precision medicine: AI’s impact on pharma
Drug development has traditionally followed a…
Rx Propellant appoints Ashish Singh as CEO and MD
Rx Propellant, science and R&D infrastructure platform established by Actis, growth market investor in sustainable…
Kapiva launches ₹50 Crore innovation fund to build evidence-based, future-ready ayurveda ecosystem
Kapiva, India’s first modern holistic Ayurvedic brand for millennials, today announced the launch of the Kapiva Innovation Fund…
The next wave of growth will belong not to the fastest manufacturers but to the most innovative…
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening…
The R&D playbook for complex generics
Dr Rakesh Bhasin, Head R&D (Formulations), Biocon, gave a presentation on 'The R&D playbook for complex generics'. He…
CPHI Frankfurt 2025 to attract 60,000+ pharma professionals; unveils new feature zones
CPHI Frankfurt 2025 is all set to take the stage from October 28 to 30 at Messe Frankfurt. The three-day event is expected to draw…
IGI and AbbVie announce exclusive global licensing agreement for ISB 2001
IGI Therapeutics, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation (IGI), and AbbVie has announced an…
Syngene International announces third year of STEM scholarship for women
Syngene International in partnership with the Research and Innovation Circle of Hyderabad (RICH) and Biocon Foundation, announced…
Panel Discussion: Accelerating OSD innovation: From R&D to market
The first panel discussion at FDD Conclave 2025 was on ‘Accelerating OSD innovation: From R&D to Market’. It set the tone for…